+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Blood Banking Market by Type, Product, End-User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 190 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 6010966
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Blood Banking Market grew from USD 15.01 billion in 2023 to USD 16.89 billion in 2024. It is expected to continue growing at a CAGR of 12.99%, reaching USD 35.31 billion by 2030.

The scope and definition of blood banking encompass the collection, testing, processing, storage, and distribution of blood and blood components for transfusion. This plays a vital role in healthcare by ensuring the availability of safe and adequate blood supplies for patients in need, which is essential for surgeries, trauma care, cancer treatment, and managing chronic illnesses. The necessity of blood banking is underscored by its critical application in both emergency and routine medical care, serving hospitals, clinics, and research institutions. With the increasing prevalence of chronic diseases, rising surgical procedures, and advancements in regenerative medicine, the end-use scope of blood banking is expanding rapidly.

Key influencing growth factors in the blood banking market include technological advancements in blood preservation and storage, increasing awareness about blood donation, and stringent government regulations emphasizing blood safety. Additionally, the emerging demand for plasma-derived medicines and the rising incidences of transfusion-transmissible infections demanding more rigorous testing regimes present potential opportunities. Companies can capitalize on these trends by innovating in automation and data management systems to enhance efficiency and traceability, investing in advanced testing technologies, and exploring partnerships for expanding donor reach. However, the market faces limitations from high operational costs, logistical challenges, and a shortage of blood donors in several regions, which constrain growth.

For business growth, areas of innovation and research include developing synthetic blood substitutes, enhancing donor recruitment and retention through technology-enabled platforms, and improving cold chain logistics. Investments in machine learning and AI for donor data analytics to proactive manage supply and demand can offer significant insights and operational benefits. The evolving regulatory landscape necessitates a focus on compliance and adopting technology to meet new standards. The nature of the market is dynamic, characterized by continual advancements in medical science and technology, presenting both challenges and exciting potential for growth and improvement in blood banking systems.

Understanding Market Dynamics in the Blood Banking Market

The Blood Banking Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • High prevalence of hematologic diseases and rising incidences of accidental cases
    • Growing burden of blood-borne diseases coupled with the increasing prevalence of transfusion transmissible infection and surgeries
    • Government and non-government initiatives such as conduction of blood donation camps
    • High prevalence of transfusion transmissible infections such as HIV and hepatitis B
  • Market Restraints
    • High cost of maintenance and blood processing equipment
  • Market Opportunities
    • Increasing demand for advanced instruments
    • Positively changing reimbursement scenarios
    • Growing awareness about blood donation and safe blood transfusion
  • Market Challenges
    • Stringent rules and regulations scenario

Exploring Porter’s Five Forces for the Blood Banking Market

Porter’s Five Forces framework further strengthens the insights of the Blood Banking Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Blood Banking Market

External macro-environmental factors deeply influence the performance of the Blood Banking Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Blood Banking Market

The Blood Banking Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Blood Banking Market

The Blood Banking Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Blood Banking Market

The Blood Banking Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Blood Banking Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AMAG Pharmaceuticals, Inc., Americord Registry LLC, Beckman Coulter, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories Inc, bioMérieux SA, Cardinal Health, Inc, China Biologic Products, Inc., Cordlife Group Limited, F. Hoffmann-La Roche Ltd, Fresenius Kabi AG, Immucor, Inc., Johnson & Johnson, Krew Instruments Pvt Ltd, Macopharma SA, Narang Medical Limited, Remi Elektrotechnik Limited, Terumo BCT, Inc., Thermo Fisher Scientific Inc., and ViaCord LLC.

Market Segmentation & Coverage

This research report categorizes the Blood Banking Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Type
    • Private
    • Public
  • Product
    • Plasma
    • Platelets
    • Red Blood Cells
    • White Blood Cells
    • Whole Blood
  • End-User
    • Ambulatory Surgical Centers
    • Diagnostic Centers
    • Hospitals
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. High prevalence of hematologic diseases and rising incidences of accidental cases
5.1.1.2. Growing burden of blood-borne diseases coupled with the increasing prevalence of transfusion transmissible infection and surgeries
5.1.1.3. Government and non-government initiatives such as conduction of blood donation camps
5.1.1.4. High prevalence of transfusion transmissible infections such as HIV and hepatitis B
5.1.2. Restraints
5.1.2.1. High cost of maintenance and blood processing equipment
5.1.3. Opportunities
5.1.3.1. Increasing demand for advanced instruments
5.1.3.2. Positively changing reimbursement scenarios
5.1.3.3. Growing awareness about blood donation and safe blood transfusion
5.1.4. Challenges
5.1.4.1. Stringent rules and regulations scenario
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Blood Banking Market, by Type
6.1. Introduction
6.2. Private
6.3. Public
7. Blood Banking Market, by Product
7.1. Introduction
7.2. Plasma
7.3. Platelets
7.4. Red Blood Cells
7.5. White Blood Cells
7.6. Whole Blood
8. Blood Banking Market, by End-User
8.1. Introduction
8.2. Ambulatory Surgical Centers
8.3. Diagnostic Centers
8.4. Hospitals
9. Americas Blood Banking Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Blood Banking Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Blood Banking Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.4. Strategy Analysis & Recommendation
LIST OF FIGURES
FIGURE 1. BLOOD BANKING MARKET RESEARCH PROCESS
FIGURE 2. BLOOD BANKING MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL BLOOD BANKING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL BLOOD BANKING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL BLOOD BANKING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BLOOD BANKING MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 7. GLOBAL BLOOD BANKING MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL BLOOD BANKING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 9. GLOBAL BLOOD BANKING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL BLOOD BANKING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 11. GLOBAL BLOOD BANKING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. AMERICAS BLOOD BANKING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 13. AMERICAS BLOOD BANKING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. UNITED STATES BLOOD BANKING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 15. UNITED STATES BLOOD BANKING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. ASIA-PACIFIC BLOOD BANKING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. ASIA-PACIFIC BLOOD BANKING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BLOOD BANKING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BLOOD BANKING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. BLOOD BANKING MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 21. BLOOD BANKING MARKET, FPNV POSITIONING MATRIX, 2023
LIST OF TABLES
TABLE 1. BLOOD BANKING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL BLOOD BANKING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BLOOD BANKING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BLOOD BANKING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. BLOOD BANKING MARKET DYNAMICS
TABLE 7. GLOBAL BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BLOOD BANKING MARKET SIZE, BY PRIVATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BLOOD BANKING MARKET SIZE, BY PUBLIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BLOOD BANKING MARKET SIZE, BY PLASMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BLOOD BANKING MARKET SIZE, BY PLATELETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BLOOD BANKING MARKET SIZE, BY RED BLOOD CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BLOOD BANKING MARKET SIZE, BY WHITE BLOOD CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BLOOD BANKING MARKET SIZE, BY WHOLE BLOOD, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BLOOD BANKING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BLOOD BANKING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BLOOD BANKING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS BLOOD BANKING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 24. ARGENTINA BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 25. ARGENTINA BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 26. ARGENTINA BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 27. BRAZIL BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 28. BRAZIL BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 29. BRAZIL BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 30. CANADA BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 31. CANADA BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 32. CANADA BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 33. MEXICO BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 34. MEXICO BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 35. MEXICO BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 37. UNITED STATES BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 38. UNITED STATES BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 39. UNITED STATES BLOOD BANKING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 40. ASIA-PACIFIC BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 41. ASIA-PACIFIC BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 42. ASIA-PACIFIC BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 43. ASIA-PACIFIC BLOOD BANKING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 44. AUSTRALIA BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 45. AUSTRALIA BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 46. AUSTRALIA BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 47. CHINA BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 48. CHINA BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 49. CHINA BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 50. INDIA BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 51. INDIA BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 52. INDIA BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 53. INDONESIA BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 54. INDONESIA BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 55. INDONESIA BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 56. JAPAN BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 57. JAPAN BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 58. JAPAN BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 59. MALAYSIA BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 60. MALAYSIA BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 61. MALAYSIA BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 62. PHILIPPINES BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 63. PHILIPPINES BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 64. PHILIPPINES BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 65. SINGAPORE BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 66. SINGAPORE BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 67. SINGAPORE BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 68. SOUTH KOREA BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 69. SOUTH KOREA BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 70. SOUTH KOREA BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 71. TAIWAN BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 72. TAIWAN BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 73. TAIWAN BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 74. THAILAND BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 75. THAILAND BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 76. THAILAND BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 77. VIETNAM BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 78. VIETNAM BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 79. VIETNAM BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 83. EUROPE, MIDDLE EAST & AFRICA BLOOD BANKING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 84. DENMARK BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 85. DENMARK BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 86. DENMARK BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 87. EGYPT BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 88. EGYPT BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 89. EGYPT BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 90. FINLAND BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 91. FINLAND BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 92. FINLAND BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 93. FRANCE BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 94. FRANCE BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 95. FRANCE BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 96. GERMANY BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 97. GERMANY BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 98. GERMANY BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 99. ISRAEL BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 100. ISRAEL BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 101. ISRAEL BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 102. ITALY BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 103. ITALY BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 104. ITALY BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 105. NETHERLANDS BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 106. NETHERLANDS BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 107. NETHERLANDS BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 108. NIGERIA BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 109. NIGERIA BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 110. NIGERIA BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 111. NORWAY BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 112. NORWAY BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 113. NORWAY BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 114. POLAND BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 115. POLAND BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 116. POLAND BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 117. QATAR BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 118. QATAR BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 119. QATAR BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 120. RUSSIA BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 121. RUSSIA BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 122. RUSSIA BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 123. SAUDI ARABIA BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 124. SAUDI ARABIA BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 125. SAUDI ARABIA BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 126. SOUTH AFRICA BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 127. SOUTH AFRICA BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 128. SOUTH AFRICA BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 129. SPAIN BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 130. SPAIN BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 131. SPAIN BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 132. SWEDEN BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 133. SWEDEN BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 134. SWEDEN BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 135. SWITZERLAND BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 136. SWITZERLAND BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 137. SWITZERLAND BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 138. TURKEY BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 139. TURKEY BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 140. TURKEY BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 141. UNITED ARAB EMIRATES BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 142. UNITED ARAB EMIRATES BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 143. UNITED ARAB EMIRATES BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 144. UNITED KINGDOM BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 145. UNITED KINGDOM BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 146. UNITED KINGDOM BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 147. BLOOD BANKING MARKET SHARE, BY KEY PLAYER, 2023
TABLE 148. BLOOD BANKING MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Blood Banking market, which are profiled in this report, include:
  • Abbott Laboratories
  • AMAG Pharmaceuticals, Inc.
  • Americord Registry LLC
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories Inc
  • bioMérieux SA
  • Cardinal Health, Inc
  • China Biologic Products, Inc.
  • Cordlife Group Limited
  • F. Hoffmann-La Roche Ltd
  • Fresenius Kabi AG
  • Immucor, Inc.
  • Johnson & Johnson
  • Krew Instruments Pvt Ltd
  • Macopharma SA
  • Narang Medical Limited
  • Remi Elektrotechnik Limited
  • Terumo BCT, Inc.
  • Thermo Fisher Scientific Inc.
  • ViaCord LLC

Methodology

Loading
LOADING...

Table Information